Abstract
Florenal, a new antiviral preparation, has shown inhibitory action on the cytopathic effect of herpesvirus in tissue culture. Florenal had a marked therapeutic effect in mice challenged intracerebrally with the herpesvirus. Clinical evaluation of herpetic keratitis, adenovirus conjunctivitis, and epidemic keratoconjunctivitis patients treated with Florenal ophthalmic ointment revealed a good therapeutic response.